Skip to search formSkip to main contentSkip to account menu

Insulin Aspart

Known as: B28asp, Insulin, Insulin, Aspartic Acid(B28)-, Insulin Aspart [Chemical/Ingredient] 
Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.
National Institutes of Health

Related topics

Related topics

10 relations

Broader (1)

Hypoglycemic Agents
In BloodInsulin, Aspart, HumanProcess of secretionaspects of radiation effects

Narrower (2)

NovoLoginsulin aspart, insulin aspart protamine drug combination 30:70

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Abstract Background: Faster aspart is insulin aspart (IAsp) in a new formulation, which in continuous subcutaneous insulin… 
2009
2009
Three different premixed combinations of biphasic insulin aspart – comparison of the efficacy and safety in a randomized controlled clinical trial in subjects with type 2 diabetes
Aim:  To evaluate clinical efficacy and safety of biphasic insulin aspart (BIAsp) 30 twice daily (b.i.d.) vs. BIAsp 50 or BIAsp… 
2006
2006
Within-patient variation of the pharmacokinetics of subcutaneously injected biphasic insulin aspart as assessed by compartmental modelling
Aims/hypothesisPharmacokinetics of s.c. administered insulin preparations have been widely studied, mostly using descriptive… 
2005
2005
The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
2004
2004
The human insulin analog aspart can induce insulin allergy.
The human insulin analog aspart is produced by recombinant technology that replaces the proline at position 28 on the β-chain of… 
Review
2002
Review
2002
Novel insulins: expanding options in diabetes management.
2002
2002
Insulin Aspart (AspB28 Human Insulin) Derivatives Formed in Pharmaceutical Solutions
AbstractPurpose. To isolate and identify the main insulin aspart (AspB28 human insulin) derivatives formed in pharmaceuticals (pH… 
Highly Cited
2001
Highly Cited
2001
Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.
OBJECTIVE The purpose of this study was to compare the efficacy, safety and pump compatibility of insulin aspart (a rapid-acting… 
Review
2001
Review
2001
Recent advances in treatment of youth with Type 1 diabetes: better care through technology
While treatment of Type 1 diabetes mellitus (T1DM) in children and adolescents is especially difficult, recent technological… 
1999
1999
Insulin aspart. Commentaries
Insulin aspart is a recombinant analogue of human insulin. Following subcutaneous insulin injection (0.15 to 0.2 U/kg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)